Factors involved in the conversion from video-assisted thoracoscopic surgery decortication to open thoracotomy in non-complicated, non-MDR/XDR stage III tuberculous empyema patients: A retrospective intention-to-treat study

被引:0
|
作者
Sun, Dangze [1 ]
Ding, Chao [1 ]
Dang, Liyun [1 ]
Yue, Xiaotong [1 ]
Wu, Weitong [1 ]
Wang, Bei [1 ]
机构
[1] Xian Chest Hosp, Dept Thorac Surg, East Xian Aerosp Ave, Xian 710061, Peoples R China
关键词
Empyema; Tuberculous; VATS; Intraoperative conversion to thoracotomy; Factor analysis;
D O I
10.1016/j.heliyon.2024.e35939
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: This retrospective intention-to-treat study aims to identify risk factors associated with intraoperative conversion from Video-Assisted Thoracoscopic Surgery (VATS) Decortication to open thoracotomy in patients with Stage III Tuberculous Empyema, specifically focusing on non-Multi-Drug Resistant (MDR)/Extensively Drug-Resistant (XDR) cases. Methods: The study included 122 patients with non-MDR/XDR tuberculous empyema who were initially scheduled for VATS decortication. Patients were divided into two groups: the Thoracoscopy group (n = 64), who successfully underwent VATS decortication, and the Conversion group (n = 58), who required intraoperative conversion to open thoracotomy. Complex cases were excluded from the study. The analysis focused solely on factors leading to conversion, rather than overall treatment outcomes. Results: A notable difference was observed in the rate of regular preoperative glucocorticoid utilization between the two cohorts, with the Conversion group exhibiting a lower percentage (46.5 %) in comparison to the Thoracoscopy group (75.0 %). Furthermore, the Thoracoscopy group displayed a significantly reduced frequency of ipsilateral lung abnormalities prior to the surgery (37.5 %), as opposed to that of the Conversion group (65.5 %). Multivariate logistic regression analysis revealed that the regular preoperative glucocorticoid use (odds ratio (OR) = 3.444, 95 % confidence interval (CI): 1.602-7.407) and pre-existing pulmonary lesions (OR = 0.31, 95%CI: 0.150-0.663) were potential influential factors. Conclusion: Inconsistent preoperative glucocorticoid administration and ipsilateral lung lesions were identified as exacerbating factors leading to the complexity of VATS decortication by causing intraoperative pulmonary tissue contusion or hemorrhage, thus hindering the successful completion of VATS decortication and necessitating a conversion to thoracotomy. Awareness of these factors can aid surgeons in making well-informed decisions regarding the preoperative surgical approach.
引用
收藏
页数:8
相关论文
共 4 条
  • [1] Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Following Neoadjuvant Immunochemotherapy in Resectable Stage III Non-Small Cell Lung Cancer Among Chinese Populations: A Multi-Center Retrospective Cohort Study
    Pan, Hanbo
    Chen, Hang
    Kong, Weicheng
    Ning, Junwei
    Ge, Zhen
    Tian, Yu
    Zou, Ningyuan
    Zhu, Hongda
    Zhang, Jiaqi
    Tao, Yixing
    Gu, Zenan
    Zheng, Min
    Ruan, Guomo
    Jiang, Long
    Li, Ziming
    Huang, Jia
    Zhou, Chengwei
    Xu, Guodong
    Luo, Qingquan
    CLINICAL LUNG CANCER, 2024, 25 (05) : 395 - 406.e5
  • [2] The efficacy and safety of uniportal video-assisted thoracic surgery on the treatment for stage II-III tuberculous empyema: a single-arm clinical retrospective study from 2016 to 2021 in a thoracic surgery center in China
    Sun, Wenwen
    Yin, Guidong
    Cai, Haomin
    Zhou, Yiming
    Gu, Jin
    Chen, Shanhao
    Fan, Lin
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [3] The efficacy and safety of uniportal video-assisted thoracic surgery on the treatment for stage II-III tuberculous empyema: a single-arm clinical retrospective study from 2016 to 2021 in a thoracic surgery center in China
    Wenwen Sun
    Guidong Yin
    Haomin Cai
    Yiming Zhou
    Jin Gu
    Shanhao Chen
    Lin Fan
    BMC Pulmonary Medicine, 22
  • [4] Video Assisted Thoracoscopic Surgery Versus Thoracotomy Following Neoadjuvant Immunochemotherapy in Resectable Stage III Non-Small Cell Lung Cancer Among Chinese Population: A Multicenter Retrospective Cohort Study
    Pan, Hanbo
    Luo, Qingquan
    CLINICAL LUNG CANCER, 2024, 25 (08) : e455 - e456